Global Nifedipine Market Insights, Forecast to 2025

Publisher Name :
Date: 21-May-2019
No. of pages: 118
Inquire Before Buying

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. 

The global Nifedipine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nifedipine market based on company, product type, end user and key regions.

This report studies the global market size of Nifedipine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nifedipine in these regions.

This research report categorizes the global Nifedipine market by top players/brands, region, type and end user. This report also studies the global Nifedipine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Bayer (Germany)

- Actavis (USA)

- Teva (Israel)

- Pfizer (USA)

- Shyndec (China)

- Honglin (China)

- Huanghai (China)

- Yabao (China)

Market size by Product

- Nifedipine Controlled Release Tablets

- Nifedipine Extended Action Tablets

Market size by End User

- Primary Pulmonary Hypertension

- Heart Failure

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Nifedipine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Nifedipine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Nifedipine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Nifedipine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Nifedipine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nifedipine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Nifedipine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Nifedipine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Nifedipine Market Size Growth Rate by Product
1.4.2 Nifedipine Controlled Release Tablets
1.4.3 Nifedipine Extended Action Tablets
1.5 Market by End User
1.5.1 Global Nifedipine Market Size Growth Rate by End User
1.5.2 Primary Pulmonary Hypertension
1.5.3 Heart Failure
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nifedipine Market Size
2.1.1 Global Nifedipine Revenue 2014-2025
2.1.2 Global Nifedipine Sales 2014-2025
2.2 Nifedipine Growth Rate by Regions
2.2.1 Global Nifedipine Sales by Regions
2.2.2 Global Nifedipine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Nifedipine Sales by Manufacturers
3.1.1 Nifedipine Sales by Manufacturers
3.1.2 Nifedipine Sales Market Share by Manufacturers
3.1.3 Global Nifedipine Market Concentration Ratio (CR5 and HHI)
3.2 Nifedipine Revenue by Manufacturers
3.2.1 Nifedipine Revenue by Manufacturers (2014-2019)
3.2.2 Nifedipine Revenue Share by Manufacturers (2014-2019)
3.3 Nifedipine Price by Manufacturers
3.4 Nifedipine Manufacturing Base Distribution, Product Types
3.4.1 Nifedipine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nifedipine Product Type
3.4.3 Date of International Manufacturers Enter into Nifedipine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Nifedipine Sales by Product
4.2 Global Nifedipine Revenue by Product
4.3 Nifedipine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Nifedipine Breakdown Data by End User
6 North America
6.1 North America Nifedipine by Countries
6.1.1 North America Nifedipine Sales by Countries
6.1.2 North America Nifedipine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Nifedipine by Product
6.3 North America Nifedipine by End User
7 Europe
7.1 Europe Nifedipine by Countries
7.1.1 Europe Nifedipine Sales by Countries
7.1.2 Europe Nifedipine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nifedipine by Product
7.3 Europe Nifedipine by End User
8 Asia Pacific
8.1 Asia Pacific Nifedipine by Countries
8.1.1 Asia Pacific Nifedipine Sales by Countries
8.1.2 Asia Pacific Nifedipine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Nifedipine by Product
8.3 Asia Pacific Nifedipine by End User
9 Central & South America
9.1 Central & South America Nifedipine by Countries
9.1.1 Central & South America Nifedipine Sales by Countries
9.1.2 Central & South America Nifedipine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Nifedipine by Product
9.3 Central & South America Nifedipine by End User
10 Middle East and Africa
10.1 Middle East and Africa Nifedipine by Countries
10.1.1 Middle East and Africa Nifedipine Sales by Countries
10.1.2 Middle East and Africa Nifedipine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Nifedipine by Product
10.3 Middle East and Africa Nifedipine by End User
11 Company Profiles
11.1 Bayer (Germany)
11.1.1 Bayer (Germany) Company Details
11.1.2 Company Business Overview
11.1.3 Bayer (Germany) Nifedipine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer (Germany) Nifedipine Products Offered
11.1.5 Bayer (Germany) Recent Development
11.2 Actavis (USA)
11.2.1 Actavis (USA) Company Details
11.2.2 Company Business Overview
11.2.3 Actavis (USA) Nifedipine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Actavis (USA) Nifedipine Products Offered
11.2.5 Actavis (USA) Recent Development
11.3 Teva (Israel)
11.3.1 Teva (Israel) Company Details
11.3.2 Company Business Overview
11.3.3 Teva (Israel) Nifedipine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva (Israel) Nifedipine Products Offered
11.3.5 Teva (Israel) Recent Development
11.4 Pfizer (USA)
11.4.1 Pfizer (USA) Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer (USA) Nifedipine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer (USA) Nifedipine Products Offered
11.4.5 Pfizer (USA) Recent Development
11.5 Shyndec (China)
11.5.1 Shyndec (China) Company Details
11.5.2 Company Business Overview
11.5.3 Shyndec (China) Nifedipine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Shyndec (China) Nifedipine Products Offered
11.5.5 Shyndec (China) Recent Development
11.6 Honglin (China)
11.6.1 Honglin (China) Company Details
11.6.2 Company Business Overview
11.6.3 Honglin (China) Nifedipine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Honglin (China) Nifedipine Products Offered
11.6.5 Honglin (China) Recent Development
11.7 Huanghai (China)
11.7.1 Huanghai (China) Company Details
11.7.2 Company Business Overview
11.7.3 Huanghai (China) Nifedipine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Huanghai (China) Nifedipine Products Offered
11.7.5 Huanghai (China) Recent Development
11.8 Yabao (China)
11.8.1 Yabao (China) Company Details
11.8.2 Company Business Overview
11.8.3 Yabao (China) Nifedipine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Yabao (China) Nifedipine Products Offered
11.8.5 Yabao (China) Recent Development
12 Future Forecast
12.1 Nifedipine Market Forecast by Regions
12.1.1 Global Nifedipine Sales Forecast by Regions 2019-2025
12.1.2 Global Nifedipine Revenue Forecast by Regions 2019-2025
12.2 Nifedipine Market Forecast by Product
12.2.1 Global Nifedipine Sales Forecast by Product 2019-2025
12.2.2 Global Nifedipine Revenue Forecast by Product 2019-2025
12.3 Nifedipine Market Forecast by End User
12.4 North America Nifedipine Forecast
12.5 Europe Nifedipine Forecast
12.6 Asia Pacific Nifedipine Forecast
12.7 Central & South America Nifedipine Forecast
12.8 Middle East and Africa Nifedipine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nifedipine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Nifedipine Product Picture
Table Nifedipine Market Segments
Table Key Manufacturers Nifedipine Covered
Table Global Nifedipine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Nifedipine Sales Market Share by Product 2014-2025
Figure Nifedipine Controlled Release Tablets Product Picture
Table Major Manufacturers of Nifedipine Controlled Release Tablets
Figure Nifedipine Extended Action Tablets Product Picture
Table Major Manufacturers of Nifedipine Extended Action Tablets
Table Global Nifedipine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Primary Pulmonary Hypertension
Figure Heart Failure
Figure Others
Figure Nifedipine Report Years Considered
Figure Global Nifedipine Market Size 2014-2025 (Million US$)
Figure Global Nifedipine Sales 2014-2025 (K Units)
Table Global Nifedipine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Nifedipine Sales by Regions 2014-2019 (K Units)
Table Global Nifedipine Sales Market Share by Regions 2014-2019
Figure Global Nifedipine Sales Market Share by Regions 2014-2019
Figure 2018 Global Nifedipine Sales Market Share by Regions
Table Global Nifedipine Revenue by Regions 2014-2019 (Million US$)
Table Global Nifedipine Revenue Market Share by Regions 2014-2019
Figure Global Nifedipine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Nifedipine Revenue Market Share by Regions
Table Global Nifedipine Sales by Manufacturers (2014-2019) (K Units)
Table Global Nifedipine Sales Share by Manufacturers (2014-2019)
Figure Global Nifedipine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Nifedipine Revenue by Manufacturers (2014-2019) (Million USD)
Table Nifedipine Revenue Share by Manufacturers (2014-2019)
Figure Nifedipine Value Share by Manufacturers in 2018
Table Key Manufacturers Nifedipine Price (2014-2019) (USD/Unit)
Table Nifedipine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Nifedipine Product Type
Table Date of International Manufacturers Enter into Nifedipine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Nifedipine Sales by Product (2014-2019) (K Units)
Table Global Nifedipine Sales Share by Product (2014-2019)
Figure Global Nifedipine Sales Market Share by Product (2014-2019)
Figure Global Nifedipine Sales Market Share by Product in 2018
Table Global Nifedipine Revenue by Product (2014-2019) (Million US$)
Table Global Nifedipine Revenue Share by Product (2014-2019)
Figure Global Nifedipine Revenue Market Share by Product (2014-2019)
Figure Global Nifedipine Revenue Market Share by Product in 2018
Table Nifedipine Price by Product 2014-2019 (USD/Unit)
Table Global Nifedipine Sales by End User (2014-2019) (K Units)
Table Global Nifedipine Sales Share by End User (2014-2019)
Figure Global Sales Nifedipine Market Share by End User (2014-2019)
Figure Global Sales Nifedipine Market Share by End User in 2018
Figure North America Nifedipine Sales Growth Rate 2014-2019 (K Units)
Figure North America Nifedipine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Nifedipine Sales by Countries (2014-2019) (K Units)
Table North America Nifedipine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Nifedipine Sales Market Share by Countries
Table North America Nifedipine Revenue by Countries (2014-2019) (Million US$)
Table North America Nifedipine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Nifedipine Revenue Market Share by Countries
Figure United States Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure United States Nifedipine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Nifedipine Sales by Product (2014-2019) (K Units)
Table North America Nifedipine Sales Market Share by Product (2014-2019)
Figure 2018 North America Nifedipine Market Share by Product
Table North America Nifedipine Sales by End User (2014-2019) (K Units)
Table North America Nifedipine Sales Market Share by End User (2014-2019)
Figure 2018 North America Nifedipine Market Share by End User
Figure Europe Nifedipine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Nifedipine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Nifedipine Sales by Countries (2014-2019) (K Units)
Table Europe Nifedipine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Nifedipine Sales Market Share by Countries
Table Europe Nifedipine Revenue by Countries (2014-2019) (Million US$)
Table Europe Nifedipine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Nifedipine Revenue Market Share by Countries
Figure Germany Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure France Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure UK Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Nifedipine Sales by Product (2014-2019) (K Units)
Table Europe Nifedipine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Nifedipine Market Share by Product
Table Europe Nifedipine Sales by End User (2014-2019) (K Units)
Table Europe Nifedipine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Nifedipine Market Share by End User
Figure Asia Pacific Nifedipine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Nifedipine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Nifedipine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Nifedipine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Nifedipine Sales Market Share by Countries
Table Asia Pacific Nifedipine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Nifedipine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Nifedipine Revenue Market Share by Countries
Figure China Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure China Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure India Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Nifedipine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Nifedipine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Nifedipine Market Share by Product
Table Asia Pacific Nifedipine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Nifedipine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Nifedipine Market Share by End User
Figure Central & South America Nifedipine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Nifedipine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Nifedipine Sales by Countries (2014-2019) (K Units)
Table Central & South America Nifedipine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Nifedipine Sales Market Share by Countries
Table Central & South America Nifedipine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Nifedipine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Nifedipine Revenue Market Share by Countries
Figure Brazil Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Nifedipine Sales by Product (2014-2019) (K Units)
Table Central & South America Nifedipine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Nifedipine Market Share by Product
Table Central & South America Nifedipine Sales by End User (2014-2019) (K Units)
Table Central & South America Nifedipine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Nifedipine Market Share by End User
Figure Middle East and Africa Nifedipine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Nifedipine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Nifedipine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Nifedipine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Nifedipine Sales Market Share by Countries
Table Middle East and Africa Nifedipine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Nifedipine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Nifedipine Revenue Market Share by Countries
Figure GCC Countries Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Nifedipine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Nifedipine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Nifedipine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Nifedipine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Nifedipine Market Share by Product
Table Middle East and Africa Nifedipine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Nifedipine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Nifedipine Market Share by End User
Table Bayer (Germany) Company Details
Table Bayer (Germany) Nifedipine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer (Germany) Recent Development
Table Actavis (USA) Company Details
Table Actavis (USA) Nifedipine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Actavis (USA) Recent Development
Table Teva (Israel) Company Details
Table Teva (Israel) Nifedipine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva (Israel) Recent Development
Table Pfizer (USA) Company Details
Table Pfizer (USA) Nifedipine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer (USA) Recent Development
Table Shyndec (China) Company Details
Table Shyndec (China) Nifedipine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shyndec (China) Recent Development
Table Honglin (China) Company Details
Table Honglin (China) Nifedipine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Honglin (China) Recent Development
Table Huanghai (China) Company Details
Table Huanghai (China) Nifedipine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Huanghai (China) Recent Development
Table Yabao (China) Company Details
Table Yabao (China) Nifedipine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Yabao (China) Recent Development
Table Global Nifedipine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Nifedipine Sales Market Share Forecast by Regions 2019-2025
Table Global Nifedipine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Nifedipine Revenue Market Share Forecast by Regions 2019-2025
Table Global Nifedipine Sales Forecast by Product 2019-2025 (K Units)
Table Global Nifedipine Sales Market Share Forecast by Product 2019-2025
Table Global Nifedipine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Nifedipine Revenue Market Share Forecast by Product 2019-2025
Table Global Nifedipine Sales Forecast by End User 2019-2025 (K Units)
Table Global Nifedipine Sales Market Share Forecast by End User 2019-2025
Figure North America Nifedipine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Nifedipine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Nifedipine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Nifedipine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Nifedipine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Nifedipine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Nifedipine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Nifedipine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Nifedipine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Nifedipine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Nifedipine Value Chain
Table Nifedipine Customers List
Table Nifedipine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs